• BSE
  • NSE
    • {{d.cmpname}}
    • {{d.price}}
    • ({{d.PerChg}}%)
Equity | News | Hot Pursuit
Hot Pursuit
Gujarat Kidney and Super Speciality jumps on debut
(10:26, 30 Dec 2025)
The stock debuted at Rs 120.75, marking a premium of 5.92% to the issue price.

So far, the stock has hit a high of 123.25 and a low of 114. On the BSE, over 11.13 lakh shares of the company were traded in the counter so far.

Gujarat Kidney and Super Speciality was subscribed 5.21 times. The issue opened for bidding on 22 December 2025 and it closed on 24 December 2025. The price band of the IPO was fixed between Rs 108 and 114 per share.

The IPO comprised a fresh issue of equity shares, aggregating up to Rs 250.8 crore.

The objectives of the fresh issue are to utilize Rs 77 crore towards the acquisition of Parekh's Hospital in Ahmedabad; Rs 12.4 crore will be used for part-payment of the purchase consideration for the already acquired Ashwini Medical Centre; Rs 10.78 crore is earmarked for the acquisition of additional shareholding in the subsidiary, Harmony Medicare, located in Bharuch; Rs 30.09 crore towards funding its capital expenditure requirements; Rs 6.82 crore will be utilized for the purchase of robotics equipment for Gujarat Kidney & Super Specialty Hospital in Vadodara; Rs 1.2 crore will be used for the repayment and/or prepayment of certain outstanding borrowings; and the remaining proceeds will be used for general corporate purposes.

The promoters are Dr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda, and Anitaben Yashwantsinh Bharpoda. The promoters and promoter group hold an aggregate of 5,63,33,900 equity shares, aggregating to 99.1% of the pre-offer issued and paid-up equity share capital. Their post-IPO shareholding is expected to be around 71.45%.

Ahead of the IPO of Gujarat Kidney and Super Speciality on 22 December 2025, the company raised Rs 100.01 crore from anchor investors by allotting 87.73 lakh shares at Rs 114 each to 10 anchor investors.

Gujarat Kidney & Super Speciality specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India. The company operates seven multispecialty hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.

Comprehensive medical care is provided across a range of specialty and super-specialty services. Treatment is offered across areas such as internal medicine, general surgery, nephrology, urology, cardiology, and orthopedics, while also focusing on advanced super-specialty care, including renal transplantation, vascular surgery, and hematology, among others. Healthcare services are categorized as secondary services, which are surgical services, and tertiary services, which are super specialty surgical services.

Central, state, and local government bodies contributed 5.46% to its revenue, insurers through third-party administrators 13.9%, and self-payers and others 80.64% in Q1 FY2026.

For the three months ended 30 June 2025, the firm recorded a consolidated net profit of Rs 4.84 crore and income from operations of Rs 15.26 crore.

Powered by Capital Market - Live News

.
Stock Broker Name Registration Number Registered Address Branch Address Contact Number Email id
DB (International) Stock Brokers Limited INZ000179035 (BROKING)

IN-DP-CDSL-266-2004 (DEPOSITORY)
Unit No. 210/211/211A at 2nd floor, Dalal Street Commercial Cooperative Society Ltd, Block No.53, Zone 5, Gift City, Gandhinagar, Gujarat-382355 Head Office – 114, New Delhi House, 27 Barakhamba Road, Delhi 110001 011-43606162 compliance@dbonline.in
51, Mini Market T/F Mandir Wali Gali, Yusaf Sarai, New Delhi 110016 011-35936102 greenpark@dbonline.in
C-12, DB Plaza, RDC Raj Nagar, Ghaziabad 201002 0120-4150393 ghaziabad@dbonline.in
Plot No 4, Wasme House, Film City Sector 16A, Noida – 201301 0120-4823200 compliance@dbonline.in
Out Side Jassusar Gate, Bikaner, Rajasthan – 334001 9001643408 bikaner@dbonline.in
Office No 101, City Center, Opp. High Court, M G Road, Indore 452001 9424083019 brajeshsadani@dbonline.in
203, Marshal House 25, Strand Road, Kolkata 700001 033-40055270 b032@dbonline.in
Shop No.-7, 2nd Floor, Amar Complex, Opp. Hanumaan Mandir, The Mall, Solan- 173212 6230604596 parwanoo@dbonline.in
Daga Commodities Private Limited INZ000028833 114, New Delhi House, 27 Barakhamba Road, Delhi 110001- 0120-4823200 compliance@dbonline.in
Daga Business (International) Stock Brokers (IFSC) Private Limited INZ000202436 Unit No. 228, Signature Building, Second Floor, Block 13B, Zone-1, Gift SEZ, Gandhinagar, Gujarat 382355 - 0120-4823200 compliance@dbonline.in

Disclosure regarding proprietary trading:

As required under Circular No. SEBI/MRD/SE/Cir-42/2003 dated 19.11.2003 issued by the Securities and Exchange Board of India; We hereby disclose that in addition to client based business, We are also doing proprietary trading.

Investor Grievances Email ID: investorgrievance@dbonline.in


Copyright © 2016 All rights Reserved DB (International) Stock Brokers Ltd.     Designed, Developed and content powered by C-MOTS Infotech( ISO 9001:2015 certified )
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors."          "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Attention Investors ::
subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries | Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. | Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors"